Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9121)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2015 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Urayama S. Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol 2015; 21(6): 1707-1717 [PMID: 25684935 DOI: 10.3748/wjg.v21.i6.1707] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i6/1707.htm |
| Number | Citing Articles |
| 1 |
Nagendra Sastry Yarla, Olga Sukocheva, Ilaria Peluso, Swathi Putta, Pallaval Veera Bramhachari, Rajesh Yadala, Dinesh K. Tiwari, Srinivas Jagarlamudi, Luciana Scotti, Marcus T. Scotti, Marcella Reale, Mohammad Amjad Kamal, Ashraf Ghulam, Bechan Sharma, Madhukiran Parvathaneni, Chinthalapally V. Rao, Mastan Mannarapu, Anupam Bishayee. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 403 doi: 10.1007/978-981-10-6728-0_30
|
| 2 |
Houria Boulaiz, María C. Ramos, Carmen Griñán-Lisón, Maria E. García-Rubiño, Francisca Vicente, Juan Antonio Marchal. What’s new in the diagnosis of pancreatic cancer: a patent review (2011-present). Expert Opinion on Therapeutic Patents 2017; 27(12): 1319 doi: 10.1080/13543776.2017.1379991
|
| 3 |
Kaiwei Xu, Zhoujian Qiu, Liu Xu, Xuedan Qiu, Lu Hong, Jianhua Wang. Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer. Biomarkers in Medicine 2021; 15(12): 977 doi: 10.2217/bmm-2020-0750
|
| 4 |
Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello, Silvio Aime, Paola Cappello, Francesco Novelli. Endogenous glutamine decrease is associated with pancreatic cancer progression. Oncotarget 2017; 8(56): 95361 doi: 10.18632/oncotarget.20545
|
| 5 |
Sumit Sahni, Advait R. Pandya, William J. Hadden, Christopher B. Nahm, Sarah Maloney, Victoria Cook, James A. Toft, Lorna Wilkinson‐White, Anthony J. Gill, Jaswinder S. Samra, Anthony Dona, Anubhav Mittal. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. International Journal of Cancer 2021; 148(6): 1508 doi: 10.1002/ijc.33368
|
| 6 |
Rui Zhao, Shuai Ren, Changyin Li, Kai Guo, Zipeng Lu, Lei Tian, Jian He, Kai Zhang, Yingying Cao, Shijia Liu, Donghui Li, Zhongqiu Wang. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Cancer Medicine 2023; 12(4): 5158 doi: 10.1002/cam4.5296
|
| 7 |
Clémentine Le Magnen, Aditya Dutta, Cory Abate-Shen. Optimizing mouse models for precision cancer prevention. Nature Reviews Cancer 2016; 16(3): 187 doi: 10.1038/nrc.2016.1
|
| 8 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 9 |
Fan Yang, Dong-Yan Liu, Jin-Tao Guo, Nan Ge, Ping Zhu, Xiang Liu, Sheng Wang, Guo-Xin Wang, Si-Yu Sun. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World Journal of Gastroenterology 2017; 23(47): 8345-8354 doi: 10.3748/wjg.v23.i47.8345
|
| 10 |
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol, Neil A. Bhowmick, Jun Gong. Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers 2023; 15(11): 3020 doi: 10.3390/cancers15113020
|
| 11 |
Munseok Choi, Minsu Park, Sung Hwan Lee, Min Jung Lee, Young‐Ki Paik, Sung Il Jang, Dong Ki Lee, Sang‐Guk Lee, Chang Moo Kang. Development of a metabolite calculator for diagnosis of pancreatic cancer. Cancer Medicine 2023; 12(15): 15933 doi: 10.1002/cam4.6233
|
| 12 |
S. Battini, F. Faitot, A. Imperiale, A. E. Cicek, C. Heimburger, G. Averous, P. Bachellier, I. J. Namer. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. BMC Medicine 2017; 15(1) doi: 10.1186/s12916-017-0810-z
|
| 13 |
Tomas Koltai. Earlier Diagnosis of Pancreatic Cancer: Is It Possible?. Cancers 2023; 15(18): 4430 doi: 10.3390/cancers15184430
|
| 14 |
Michael T. Zimmermann, Angela J. Mathison, Tim Stodola, Douglas B. Evans, Jenica L. Abrudan, Wendy Demos, Michael Tschannen, Mohammed Aldakkak, Jennifer Geurts, Gwen Lomberk, Susan Tsai, Raul Urrutia. Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.606820
|
| 15 |
Beste Turanli, Esra Yildirim, Gizem Gulfidan, Kazim Yalcin Arga, Raghu Sinha. Current State of “Omics” Biomarkers in Pancreatic Cancer. Journal of Personalized Medicine 2021; 11(2): 127 doi: 10.3390/jpm11020127
|
| 16 |
Jaroslav Tumas, Kotryna Kvederaviciute, Marius Petrulionis, Benediktas Kurlinkus, Arnas Rimkus, Greta Sakalauskaite, Jonas Cicenas, Audrius Sileikis. Metabolomics in pancreatic cancer biomarkers research. Medical Oncology 2016; 33(12) doi: 10.1007/s12032-016-0853-6
|
| 17 |
Bin Zhou, Jian‐Wei Xu, Yu‐Gang Cheng, Jing‐Yue Gao, San‐Yuan Hu, Lei Wang, Han‐Xiang Zhan. Early detection of pancreatic cancer: Where are we now and where are we going?. International Journal of Cancer 2017; 141(2): 231 doi: 10.1002/ijc.30670
|
| 18 |
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O’Reilly, Mithat Gönen, Richard G. Do, Amber L. Simpson, Surinder K. Batra. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. PLOS ONE 2017; 12(12): e0188022 doi: 10.1371/journal.pone.0188022
|
| 19 |
Haitao Zhao, Hannan Gao, Chuangwei Luo, Guangjie Yang, Xiaoyu Zhao, Shi Gao, Qingjie Ma, Bing Jia, Jiyun Shi, Fan Wang. An Integrin-αvβ6/α5β1-Bitargeted Probe for the SPECT Imaging of Pancreatic Adenocarcinoma in Preclinical and Primary Clinical Studies. Bioconjugate Chemistry 2021; 32(7): 1298 doi: 10.1021/acs.bioconjchem.1c00296
|
| 20 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 21 |
Keith Unger, Khyati Y. Mehta, Prabhjit Kaur, Yiwen Wang, Smrithi S. Menon, Shreyans K. Jain, Rose A. Moonjelly, Shubhankar Suman, Kamal Datta, Rajbir Singh, Paul Fogel, Amrita K. Cheema. Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Oncotarget 2018; 9(33): 23078 doi: 10.18632/oncotarget.25212
|
| 22 |
Jie Sun, Fangfang Bi, Yang Yang, Yuan Zhang, Aihua Jin, Jinzi Li, Zhenhua Lin. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Oncology Reports 2017; 37(2): 857 doi: 10.3892/or.2016.5302
|
| 23 |
Ryota Nakano, Shin Nishiumi, Takashi Kobayashi, Takuya Ikegawa, Yuzo Kodama, Masaru Yoshida. Possibility of detecting intraductal papillary mucinous neoplasms using metabolite biomarkers for pancreatic cancer. Biomarkers in Medicine 2020; 14(11): 1009 doi: 10.2217/bmm-2019-0587
|
| 24 |
Hua Zhao, Amy B. Heimberger, Zhimin Lu, Xifeng Wu, Tiffany R. Hodges, Renduo Song, Jie Shen. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. Oncotarget 2016; 7(15): 20486 doi: 10.18632/oncotarget.7974
|
| 25 |
Eerdunduleng Eerdunduleng. circ-LDLRAD3 regulates cell proliferation, migration and invasion of pancreatic cancer by miR-876-3p/STAT3. Clinical Surgery Research Communications 2019; 1(1): 08 doi: 10.31491/CSRC.2019.03.027
|
| 26 |
Seoung Yoon Rho, Sang-Guk Lee, Minsu Park, Jinae Lee, Sung Hwan Lee, Ho Kyoung Hwang, Min Jung Lee, Young-Ki Paik, Woo Jung Lee, Chang Moo Kang. Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55016-x
|